Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon G Lynch

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Physical Therapy|May 30, 2023
Association Between Frailty and Free-Living Walking Performance in People With Multiple SclerosisTobia Zanotto, Irina Galperin, Anat Mirelman, et al.
Journal of Neurology|November 10, 2022
Treadmill training with virtual reality to enhance gait and cognitive function among people with multiple sclerosis: a randomized controlled trialIrina Galperin, Anat Mirelman, Tanja Schmitz-Hübsch, et al.
Autoimmune Diseases|May 2, 2012
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation StudyVijayshree Yadav, Dennis N Bourdette, James D Bowen, et al.
Archives of Physical Medicine and Rehabilitation|November 28, 2021
Frailty and Falls in People Living With Multiple SclerosisTobia Zanotto, Irina Galperin, Anat Mirelman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2023
Modifying diet and exercise in multiple sclerosis (MoDEMS): A randomized controlled trial for behavioral weight loss in adults with multiple sclerosis and obesityJared M Bruce, Julia S Cozart, Robin P Shook, et al.
Archives of Physical Medicine and Rehabilitation|September 28, 2024
Effects of a 6-Week Treadmill Training With and Without Virtual Reality on Frailty in People With Multiple SclerosisTobia Zanotto, Irina Galperin, Danya Pradeep Kumar, et al.
The Lancet. Digital Health|September 29, 2023
Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trialStefan M Gold, Tim Friede, Björn Meyer, et al.
The New England Journal of Medicine|August 30, 2018
Phase 2 Trial of Ibudilast in Progressive Multiple SclerosisRobert J Fox, Christopher S Coffey, Robin Conwit, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Physical Therapy|May 30, 2023
Association Between Frailty and Free-Living Walking Performance in People With Multiple SclerosisTobia Zanotto, Irina Galperin, Anat Mirelman, et al.
Journal of Neurology|November 10, 2022
Treadmill training with virtual reality to enhance gait and cognitive function among people with multiple sclerosis: a randomized controlled trialIrina Galperin, Anat Mirelman, Tanja Schmitz-Hübsch, et al.
Autoimmune Diseases|May 2, 2012
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation StudyVijayshree Yadav, Dennis N Bourdette, James D Bowen, et al.
Archives of Physical Medicine and Rehabilitation|November 28, 2021
Frailty and Falls in People Living With Multiple SclerosisTobia Zanotto, Irina Galperin, Anat Mirelman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2023
Modifying diet and exercise in multiple sclerosis (MoDEMS): A randomized controlled trial for behavioral weight loss in adults with multiple sclerosis and obesityJared M Bruce, Julia S Cozart, Robin P Shook, et al.
Archives of Physical Medicine and Rehabilitation|September 28, 2024
Effects of a 6-Week Treadmill Training With and Without Virtual Reality on Frailty in People With Multiple SclerosisTobia Zanotto, Irina Galperin, Danya Pradeep Kumar, et al.
The Lancet. Digital Health|September 29, 2023
Internet-delivered cognitive behavioural therapy programme to reduce depressive symptoms in patients with multiple sclerosis: a multicentre, randomised, controlled, phase 3 trialStefan M Gold, Tim Friede, Björn Meyer, et al.
The New England Journal of Medicine|August 30, 2018
Phase 2 Trial of Ibudilast in Progressive Multiple SclerosisRobert J Fox, Christopher S Coffey, Robin Conwit, et al.
Pageof 7